| Name | Title | Contact Details |
|---|---|---|
Tracy Dowling |
General Counsel | Profile |
Tracy Dowling |
General Counsel, Head of Business Development | Profile |
Fubao Wang |
Senior Vice President and Head of Regulatory Affairs | Profile |
Sonoma Biotherapeutics is inventing the future of living therapies for autoimmune disease — safe, effective treatments as unique as each individual patient. Regulatory T cell therapies that harness a patient`s own immune cells, powerful next generation gene editing techniques and advanced manufacturing and quality assurance processes. Sonoma`s mission is to create a best-in-class regulatory T cell therapy that delivers long-lasting, highly efficacious treatments leading to cures across a spectrum of autoimmune and degenerative diseases.
Genentech, Inc., is a biotechnology corporation which became a subsidiary of Roche in 2009.
Shasqi develops cancer treatment intended to use bio-orthogonal chemistry for localized drug delivery.
Inceptor Bio is developing multiple next-generation cell therapy platforms to cure difficult-to-treat cancers with a focus on novel mechanisms to enhance immune cell performance in the tumor microenvironment.
Synecor is a Chapel Hill, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.